Prostatic cell lineage markers: Emergence of BCL2+ cells of human prostate cancer xenograft LuCaP 23 following castration

International Journal of Cancer

Volumn 65, Issue 1, 1996, Pages 85-89

  Liu, Alvin Y ^a   Corey, Eva ^a   Bladou, Franck ^a   Lange, Paul H ^a   Vessella, Robert L ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEURON SPECIFIC ENOLASE; PROSTATE SPECIFIC ANTIGEN; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SUBPOPULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; MOUSE; PRIORITY JOURNAL; PROSTATE CARCINOMA; TUMOR CELL LINE; TUMOR XENOGRAFT;

ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; ORCHIECTOMY; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENES; RNA, MESSENGER; RNA, NEOPLASM; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030031962     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960103)65:1<85::AID-IJC15>3.0.CO;2-H     Document Type: Article

References (21)

1. BANG, Y.-J., PIRNIA, F., FANG, W.-G, KANG, W.K., SARTOR, O., WHITESELL, L., HA, M.J., TSOKOS, M., SHEAHAN, M.D., NGUYEN, P., NIKLINSKI, W.T., MYERS, C.E. and TREPEL, J.B., Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Proc. nat. Acad. Sci. (Wash.), 91, 5330-5334 (1994).
2. BONKHOFF, H., STEIN, U. and REMBERGER, K., Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: simultaneous demonstration of cell-specific epithelial markers. Hum. Pathol., 25, 42-46 (1994a).
3. BONKHOFF, H., STEIN, U. and REMBERGER, K., The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate, 24, 114-118 (1994b).
4. BONKHOFF, H., STEIN, U. and REMBERGER, K., Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells. Hum. Pathol., 26, 167-170 (1995).
5. BONKHOFF, H., WERNERT, N., DHOM, G. and REMBERGER, K., Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate. Prostate, 19, 91-98 (1991).
6. CHEJFEC, G., CAPELLA, C., SOLCIA, E., JAO, W. and GOULD, V.E., Amphicrine cells, dysplasias. and neoplasias. Cancer, 56, 2683-2690 (1985).
7. COLOMBEL, M., OLSSON, C.A., NG, P.-Y. and BUTTYAN, R., Hormone-regulated apoptosis results from reentry of differentiated prostate cells into a defective cell cycle. Cancer Res., 52, 4313-4319 (1992).
8. COLOMBEL, M., SYMMANS, F., GIL., S., O'TOOLE, K.M., CHOPIN, D., BENSON, M., OLSSON, C.A., KORSMEYER, S. and BUTTYAN, R., Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormonerefractory human prostate cancers. Amer. J. Pathol., 143, 390-400 (1993).
9. DELELLIS, R.A., TISCHLER, A.S. and WOLFE, H.J., Multidirectional differentiation in neuroendocrine neoplasms. J. Histochem. Cytochem., 32, 899-904 (1984).
10. DI SANT'AGNESE, P.A., Neuroendocrine differentiation in human prostatic carcinoma. Hum. Pathol., 23, 287-296 (1992).
11. HENTTU, P. and VIHKO, P., Prostate-specific antigen and human glandular kallikrein: two kallikreins of the human prostate. Ann. Med., 26, 157-164 (1994).
12. HOCKENBERY, D.M., ZUTTER, M., HICKEY, W., NAHM, M. and KORSMEYER, S.J., BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. nat. Acad. Sci. (Wash.), 88, 6961-6965 (1991).
13. KYPRIANOU, N., ENGLISH, H.F. and ISAACS, J.T., Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res., 50, 3748-3753 (1990).
14. MARIN, M.C., HSU, B., MEYN, R.E., DONEHOWER, L.A., EL-NAGGAR, A.K. and MCDONNELL, T.J., Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis. Oncogens, 9, 3107-3112 (1994).
15. MARTIKAINEN, P. and ISAACS, J., Role of calcium in the programmed death of rat prostatic glandular cells. Prostate, 17, 175-187 (1990).
16. MCDONNELL, T.J., TRONCOSO, P., BRISBAY, S.M., LOGOTHETIS, C., CHUNG, L.W.K., HSIEH, J.-T., TU, S.-M. and CAMPBELL, M.L., Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res., 52, 6940-6944 (1992).
17. MIYASHITA, T., KRAJEWSKI, S., KRAJEWSKA, M., WANG, H.G., LIN, H.K., LIEBERMANN, D.A., HOFFMAN, B. and REED, J.C., Tumor suppressor p53 is a regulator of bcl-2 and box gene expression in vitro and in vivo. Oncogene, 9, 1799-1805 (1994).
18. OKADA, H., TSUBURA, A., OKAMURA, A., SENZAKI, H., NAKA, Y., KOMATZ, Y. and MORII, S., Keratin profiles in normal/hyperplastic prostates and prostate carcinoma. Virchows Archiv. A Pathol. Anat., 421, 157-161 (1992).
19. OLIVA, D., CALI, L., FEO, S. and GIALLONGO, A., Complete structure of the human gene encoding neuron-specific enolase. Genomics, 10, 157-165 (1991).
20. REED, J.C., Bcl-2 and the regulation of programmed cell death. J. Cell Biol., 124, 1-6 (1994).
21. SEGAL, N.H., COHEN, R.J., HAFFEJEE, Z. and SAVAGE, N., BCL-2 proto-oncogene expression in prostate cancer and its relationship to the prostatic neuroendocrine cell. Arch. Pathol. Lab. Med., 118, 616-618 (1994).